Inovio shareholders approve reverse stock split at ratios from 1:10 to 1:50

INOVIO PHARMACEUTICALS, INC.

146,265,973 shares (53.6%) present; reverse split approved with 96,534,629 For vs 48,857,255 Against.
Board authorized to implement split at any time within one year of Jan 12, 2024 special meeting.
Split ratio range 1-for-10 to 1-for-50, exact ratio to be determined by Board later.
Adjournment proposal also approved (106,842,257 For) to allow additional solicitation if needed.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

INOVIO PHARMACEUTICALS, INC. shareholders approved Adjournment Proposal at the 2024-01-12 meeting.

Outcome: passed
Meeting: 2024-01-12

Exact text from the filing

The votes were cast as follows: For Against Abstain 106,842,257 37,097,854 2,325,862 The Adjournment Proposal was approved.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

INOVIO PHARMACEUTICALS, INC. shareholders approved Reverse Stock Split Proposal at the 2024-01-12 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2024-01-12

Exact text from the filing

The votes were cast as follows: For Against Abstain 96,534,629 48,857,255 874,089 The Reverse Stock Split Proposal was approved.

View on SEC.gov

Browse all shareholder votes →

INOVIO PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-007674

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.